EMA

• Health

GLP-1 shortages will not resolve this year, EMA warns, amid concern over off-label use

The ongoing shortage of glucagon-like peptide 1 receptor (GLP-1) agonists such as semaglutide (marketed as Wegovy and Ozempic) is a…